Comparative efficacy and safety of tafamidis versus acoramidis in transthyretin amyloid cardiomyopathy: a matching-adjusted indirect comparison

11 May 2026 (09:37 - 10:45)
Organised by: Logo
Congress Presentation Part of: ePosters in acute heart failure (4) Clinical Delegates Premium Access Heart Failure 2026 Heart Failure Association (HFA)

ESC 365 is supported by

ESC 365 is supported by